Author Archives: sobalas

By Donna Loyle, communications manager, LIMR   Main Line Health is participating in several clinical trials that are testing devices to treat tricuspid regurgitation (TR), a condition in which blood flows through the tricuspid valve in the wrong direction during … Continue reading →

Main Line HealthCare is seeking a Utilization Management Review Physician to join their team. For more information regarding opportunity details and requirements, please see the attached job posting.

Dear Palliative Care Colleagues,   We are pleased to announce that Evan Schneidmesser MD has accepted the position of System Medical Director for Palliative Care Services effective September 1, 2020 and is transitioning from his previous Interim Medical Director status. … Continue reading →

The next Town Hall for Medical Staff will be held on Wednesday September 30 at 5:00pm. An invitation will be sent the day of the event.  

Dear Colleagues:   Fall has officially arrived and, at Main Line Health, we know that this change of season means the start of another much-anticipated annual event: the American Heart Association Heart Walk. While COVID has required us to postpone … Continue reading →

Colleagues:   It is with mixed emotions that I announce Andi Gilbert’s plans to retire on January 1, 2021 after more than twenty years of outstanding service to Main Line Health as President of Bryn Mawr Hospital and Executive Leader … Continue reading →

Andy’s memorial service will be held on Saturday, September 26 at 11 a.m. and will be private. When it is time, the service will be livestreamed through a link at westlaurelhill.com. If you cannot watch the livestream, the service will … Continue reading →

Dear Colleagues:   I know that some of you may have already read the obituary for Andy that appeared in the Inquirer but, for those of you who haven’t, please see the attached.  It beautifully reflects the man Andy was…humble, … Continue reading →

By Donna Loyle, communications manager, LIMR   EMERALD is a randomized, phase 3, multicenter clinical trial that seeks to compare the experimental oral medication elacestrant to the standard of care options of Faslodex® (fulvestrant) or an aromatase inhibitor (AI) in … Continue reading →

The Virtual MLH research, EBP and innovation conference will be on Wednesday, September 23. To register, https://mlhs.zoom.us/webinar/register/WN_Y4WOWa7aRAmX6kj6kQRc6g. For more information about the event, please see below.